Nephros Inc.

NEPH Healthcare Medical Instruments & Supplies

Nephros Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.8 million, up 32.7% from fiscal 2024.

Revenue
+18.0%
EPS
+66.7%
Free cash flow
−251.5%

Quarter to September 2026, against a year earlier

2.82 0.27 −8.74%
Market cap
$33.6M
P/E
18.0×
Fwd P/E
20.2×
Dividend yield
—
F-score
7/9
Altman Z
−3.26
Beneish M
−2.60
Dividend safety
n/a
Sep '26 From the 10-Q filed 5 Nov Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
4 4 3 7

+8 more TTM periods

ROE
16.95% 16.10% 7.76% 12.71%
ROA
13.39% 12.39% 6.07% 9.61%
ROIC
14.29% 14.11% 6.33% 14.92%
Return on Tangible Assets
17.50% 16.80% 8.56% 13.95%
Average Days of Receivables
60.60 72.15 67.20 46.90
Free Cash Flow per Share
(0.08) (0.06) (0.03) 0.16
Free Cash Flow
(0.91) (0.66) (0.35) 1.65
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026